期刊文献+

高血压患者左室向心性结构与舒张功能减退相关:HyperGEN研究 被引量:2

Left ventricular concentric geometry is associated with impaired relaxation in hypertension: The HyperGEN study
下载PDF
导出
摘要 We tested the hypothesis that abnormal left ventricular(LV) relaxation is associated with concentric LV geometry. Methods and results: Doppler LV filling properties were studied in 1384 hypertensive participants without cardiovascular disease, from the HyperGEN population(731 women, 784 obese, 236 diabetic) and compared in four LV geometry groups; normal, concentric remodelling(3.5% ), eccentric(23% ), and concentric LV hypertrophy(4% ), based on echocardiographic LV mass index(in g/m2.7). Abnormal LV relaxation was identified by European Society of Cardiology criteria in 275 subjects(20% ). After accounting for significant confounders, E/A ratio and isovolumic relaxation time were not related to the presence of LV hypertrophy, but indicated abnormal relaxation when LV geometry was concentric(both P< 0.0001). Deceleration time of E velocity was prolonged with LV hypertrophy(P< 0.03), but the behaviour in relation to concentric LV geometry differed in the presence(prolonged) or absence(reduced) of LV hypertrophy(P=0.05), a difference independently related to the magnitude of both transmitral gradients and stroke volume(all P< 0.05). Logistic regression showed that, compared with normal LV geometry, the odds of abnormal LV relaxation was 2.3- fold greater when LV geometry was concentric and that LV hypertrophy conferred a borderline higher risk than normal LV mass. Conclusions: In hypertensive individuals without prevalent cardiovascular disease from a multi-ethnic population-based sample, delayed LV relaxation is independently associated with concentric LV geometry. We tested the hypothesis that abnormal left ventricular(LV) relaxation is associated with concentric LV geometry. Methods and results: Doppler LV filling properties were studied in 1384 hypertensive participants without cardiovascular disease, from the HyperGEN population(731 women, 784 obese, 236 diabetic) and compared in four LV geometry groups; normal, concentric remodelling(3.5% ), eccentric(23% ), and concentric LV hypertrophy(4% ), based on echocardiographic LV mass index(in g/m2.7). Abnormal LV relaxation was identified by European Society of Cardiology criteria in 275 subjects(20% ). After accounting for significant confounders, E/A ratio and isovolumic relaxation time were not related to the presence of LV hypertrophy, but indicated abnormal relaxation when LV geometry was concentric(both P< 0.0001). Deceleration time of E velocity was prolonged with LV hypertrophy(P< 0.03), but the behaviour in relation to concentric LV geometry differed in the presence(prolonged) or absence(reduced) of LV hypertrophy(P=0.05), a difference independently related to the magnitude of both transmitral gradients and stroke volume(all P< 0.05). Logistic regression showed that, compared with normal LV geometry, the odds of abnormal LV relaxation was 2.3- fold greater when LV geometry was concentric and that LV hypertrophy conferred a borderline higher risk than normal LV mass. Conclusions: In hypertensive individuals without prevalent cardiovascular disease from a multi-ethnic population-based sample, delayed LV relaxation is independently associated with concentric LV geometry.
  • 相关文献

同被引文献21

  • 1Ganau A, Devereux RB, Roman MJ, et al . Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension[J]. J Am Coll Cardiol , 1992, 19(7): 1550- 1558.
  • 2Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study[J]. J Am Coll Cardiol , 1995, 25(4): 879-884.
  • 3Chobanian AV, Bakris GL, Black HR, et al . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J]. Hypertension , 2003, 42(6): 1206-1252.
  • 4Scuteri A, Cacciafesta M, Di Bernardo MG, et al. Is blood pressure the major determinant of left ventricular mass in subjects over 50 years of age[J]. Arch Gerontol Geriatr , 1996, 22 (2) : 181-194.
  • 5LANG R M, BIERIG M, DEVEREUX R B, et al; AmericanSociety of Echocardiography' s Nomenclature and StandardsCommittee; Task Force on Chamber Quantification; Ameri-can College of Cardiology Echocardiography Committee; A-merican Heart Association; European Association of Echocar-diography, European Society of Cardiology. Recommenda-tions for chamber quantification CJD. Eur J Echocardiogr,2006, 7(2):79-108.
  • 6FOPPA M, DUNCAN B B, ROHDE L E. Echocardiography-based left ventricular mass estimation, how should we definehypertrophy. [J], Cardiovasc Ultrasound, 2005, 3 (3): 17-29.
  • 7SEO Y,ISHIZU T, ENOMOTO Y, et al. Endocardial sur-face area tracking for assessment of regional LV wall deforma-tion with 3D speckle tracking imaging[J]. JACC CardiovascImag, 2011, 4(4): 358-365.
  • 8POULEUR A C, LE POLAIN DE WAROUX J B, PAS-QUET A, et al. Assessment of left ventricular mass and vol-umes by three-dimensional echocardiography in patients withor without wall motion abnormalities : comparison against cinemagnetic resonance imaging[J]. Heart,2008,94(8): 1050-1057.
  • 9IKONOMIDIS I, TZORTZIS S, PARASKEVAIDIS I,et al.Association of abnormal coronary microcirculatory functionwith impaired response of longitudinal left ventricular functionduring adenosine stress echocardiography in untreated hyper-tensive patients [J]. Eur Heart J Cardiovasc Imag. 2012,[Epub ahead of printtensive patients [J]. Eur Heart J Cardiovase Imag, 2012, [Epub ahead of print].
  • 10KANG S J, LIM H S, CHOI B J, et al. Longitudinal strainand torsion assessed by two-dimensional speckle tracking cor-relate with the serum level of tissue inhibitor of matrix metal-loproteinase-1 f a marker of myocardial fibrosis, in patientswith hypertension[J3. J Am Soc Echocardiogr, 2008, 21(8):907-911.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部